KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $94,000 | +1.1% | 13,226 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $93,000 | +22.4% | 12,844 | +3.8% | 0.00% | 0.0% |
| Q1 2017 | $76,000 | +13.4% | 12,372 | +8.9% | 0.00% | 0.0% |
| Q4 2016 | $67,000 | +15.5% | 11,362 | +3.7% | 0.00% | – |
| Q3 2016 | $58,000 | +52.6% | 10,959 | +2.8% | 0.00% | – |
| Q3 2015 | $38,000 | -71.6% | 10,664 | +1.2% | 0.00% | -100.0% |
| Q1 2015 | $134,000 | -41.0% | 10,539 | -34.4% | 0.00% | -33.3% |
| Q4 2014 | $227,000 | +16.4% | 16,074 | +13.2% | 0.00% | 0.0% |
| Q3 2014 | $195,000 | -3.5% | 14,196 | +8.2% | 0.00% | 0.0% |
| Q2 2014 | $202,000 | – | 13,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |